[Viral hepatitis A: specific immunological aspects before and after exposure to risk]. 1984

C Laverdant, and J Hainaut, and J Dutertre

The serum samples collected from 1279 healthy subjects were studied by radio-immunologic methods before they were given polyvalent immunoglobulin for hepatitis A prophylaxis. They departed all together for the endemic area at the same time. 1220 remained healthy, and serum samples (120 th day) were studied once again. Hepatitis A occurred in 59 cases. For 30 studied of them, the proof had been given at the initial phase, either by the discovery of the virus in the stool, or by detection of anti-HAV IgM. Among the subjects having anti-HAV antibodies, these, whose titer was around hundred, were better protected; the risk seemed more important for a smaller or higher anti-HAV titer. Among the subjects who came back with hepatitis A, the markers of HB had been more frequently observed in the first sample. When their anti-HAV antibodies titer is under 20, the markers of HB are significantly fewer often associated. This might mean either that these is a congenital susceptibility towards the two viruses or that prior infection by virus HB enhances the risk of hepatitis A.

UI MeSH Term Description Entries
D007116 Immunization, Passive Transfer of immunity from immunized to non-immune host by administration of serum antibodies, or transplantation of lymphocytes (ADOPTIVE TRANSFER). Convalescent Plasma Therapy,Immunoglobulin Therapy,Immunotherapy, Passive,Normal Serum Globulin Therapy,Passive Antibody Transfer,Passive Transfer of Immunity,Serotherapy,Passive Immunotherapy,Therapy, Immunoglobulin,Antibody Transfer, Passive,Passive Immunization,Therapy, Convalescent Plasma,Transfer, Passive Antibody
D006506 Hepatitis A INFLAMMATION of the LIVER in humans caused by a member of the HEPATOVIRUS genus, HUMAN HEPATITIS A VIRUS. It can be transmitted through fecal contamination of food or water. Hepatitis, Infectious,Infectious Hepatitis,Hepatitides, Infectious,Infectious Hepatitides
D006507 Hepatovirus A genus of PICORNAVIRIDAE causing infectious hepatitis naturally in humans and experimentally in other primates. It is transmitted through fecal contamination of food or water. HEPATITIS A VIRUS is the type species. Hepatitis Virus, Infectious,Infectious Hepatitis Virus,Hepatitis Viruses, Infectious,Hepatoviruses,Infectious Hepatitis Viruses
D006508 Hepatitis Antibodies Immunoglobulins raised by any form of viral hepatitis; some of these antibodies are used to diagnose the specific kind of hepatitis. Antibodies, Hepatitis
D006510 Hepatitis B Antibodies Antibodies to the HEPATITIS B ANTIGENS, including antibodies to the surface (Australia) and core of the Dane particle and those to the "e" antigens. Anti-Australia Antigens,Anti-HBAg,Anti-Hepatitis B Antigens,Anti HBAg,Hepatitis B Virus Antibodies,Anti Australia Antigens,Anti Hepatitis B Antigens,Antibodies, Hepatitis B,Antigens, Anti-Australia,Antigens, Anti-Hepatitis B,B Antibodies, Hepatitis,B Antigens, Anti-Hepatitis,HBAg, Anti
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012306 Risk The probability that an event will occur. It encompasses a variety of measures of the probability of a generally unfavorable outcome. Relative Risk,Relative Risks,Risk, Relative,Risks,Risks, Relative

Related Publications

C Laverdant, and J Hainaut, and J Dutertre
May 1972, British medical bulletin,
C Laverdant, and J Hainaut, and J Dutertre
January 1985, Voprosy virusologii,
C Laverdant, and J Hainaut, and J Dutertre
January 1966, Epatologia (Roma),
C Laverdant, and J Hainaut, and J Dutertre
January 2011, Roumanian archives of microbiology and immunology,
C Laverdant, and J Hainaut, and J Dutertre
December 1977, Minerva medica,
C Laverdant, and J Hainaut, and J Dutertre
October 1995, Gastroenterologie clinique et biologique,
C Laverdant, and J Hainaut, and J Dutertre
January 1984, Terapevticheskii arkhiv,
C Laverdant, and J Hainaut, and J Dutertre
December 1977, Schweizerische medizinische Wochenschrift,
C Laverdant, and J Hainaut, and J Dutertre
April 1975, Bulletin of the New York Academy of Medicine,
C Laverdant, and J Hainaut, and J Dutertre
December 1979, Revista de medicina de la Universidad de Navarra,
Copied contents to your clipboard!